Aptinyx to Participate in H.C. Wainwright 1st Annual Mental Health Conference
June 22 2022 - 7:47AM
Business Wire
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical
company developing transformative therapies for the treatment of
nervous system disorders, today announced that company management
will present at the H.C. Wainwright 1st Annual Mental Health
Conference. The conference is being held at the Lotte New York
Palace Hotel and virtually from June 27–28, 2022.
The presentation will be available to view on-demand beginning
at 7:00 AM ET on Monday, June 27, 2022 through the H.C. Wainwright
conference portal and on the “Events and Presentations” page in the
“Investors & Media” section of Aptinyx’s website at
https://ir.aptinyx.com. A webcast recording will be archived on
Aptinyx’s website for 30 days following the event.
About Aptinyx
Aptinyx Inc. is a clinical-stage biopharmaceutical company
focused on the discovery, development, and commercialization of
proprietary synthetic small molecules for the treatment of brain
and nervous system disorders. Aptinyx has a platform for discovery
of novel compounds that work through a unique mechanism to
modulate—rather than block or over-activate—NMDA receptors and
enhance synaptic plasticity, the foundation of neural cell
communication. The company has three product candidates in clinical
development in central nervous system indications, including
fibromyalgia, post-traumatic stress disorder, and cognitive
impairment. Aptinyx is also advancing additional compounds from its
proprietary discovery platform, which continues to generate a rich
and diverse pipeline of small-molecule NMDA receptor modulators
with the potential to treat an array of neurologic disorders. For
more information, visit www.aptinyx.com or follow Aptinyx on
Twitter @Aptinyx.
Source: Aptinyx Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220622005388/en/
Investor and Media Contact: Patrick Flavin Aptinyx Inc.
ir@aptinyx.com or corporate@aptinyx.com 847-871-0377
Aptinyx (NASDAQ:APTX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Aptinyx (NASDAQ:APTX)
Historical Stock Chart
From Oct 2023 to Oct 2024